Key result
Sleep-related respiratory disorders are an independent risk factor for cardiovascular diseases, and evaluating biomarkers can help define the cardiovascular risk in these patients.
Sleep-related respiratory disorders are a systemic disease and independent risk factor for cardiovascular diseases, highlighting the potential utility of biomarkers like NT-proBNP and troponins for risk stratification.
Answers are grounded in this paper and cite their sources.
Supports sleep disorder screening in CVD risk evaluation; leaves open prospective validation of biomarker-guided stratification.
Sleep-related respiratory disorders are a singular risk factor for cardio-vascular diseases. Biomarkers, related to the cardiovascular diseases and heart failure as a their result with the morbidity increasing with the increase of patients ’ longevity, are used as a diagnostic and prognostic factor. The study of patients with sleep-related respiratory disorders may help the construction of a panel of biochemical and instrumental tools, defining the cardiovascular risk of these patients.
No takes yet. Share an insight, caveat, or question.
Arpine Kirkorova (2018) conducted a review in Sleep-related respiratory disorders. Sleep-related respiratory disorders was evaluated. Sleep-related respiratory disorders are an independent risk factor for cardiovascular diseases, and evaluating biomarkers can help define the cardiovascular risk in these patients.
Synapse has enriched 10 related papers. Consider them for comparative context: